SIE 0.00% 6.8¢ scigen limited

SciGen has recognised the huge potential of the...

  1. 329 Posts.

    SciGen has recognised the huge potential of the Biopharmaceutical market, which is currently growing faster than any other market in the Healthcare industry. With a combination of shared wealth and increasing life expectancy of the world's population, the Biopharmaceutical market is expected to continue to grow much faster than other world markets, providing a strong foundation for SciGen's extensive biotechnological expertise and sound marketing infrastructure.

    In view of the strong government support for the biotechnology sector, SciGen has adopted an approach to its product development which, in keeping with
    government initiatives, endeavours to supply competitively priced, state-of-the-art healthcare products to the greatest majority of the world's population.

 
watchlist Created with Sketch. Add SIE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.